
Australia and New Zealand Sarcoma Association
@anzsarcoma
Followers
744
Following
622
Media
432
Statuses
710
The Australia and New Zealand Sarcoma Association is the peak body for the sarcoma community. ANZSA is formerly known as ASG and ASSG.
Melbourne, Victoria
Joined November 2016
Join us for our first Sarcoma Awareness Month webinar in collaboration with @VCCCAlliance. Register here:
0
3
3
RT @ANZCHOG: @PeterMacCC has become first site in the world activated for a key stage of INTER-EWING-1 trial, a major global program improv….
0
2
0
Congratulations to Hayden Snow and David Gyorki on the publication of their latest paper in collaboration with the @TARPSWG. A major step forward for improving outcomes for retroperitoneal sarcoma through international collaboration. Read here:
0
4
4
We’re pleased to announce that @WinshipAtEmory in the US, is the second international site to join the ReLaPSe study - a prospective study evaluating standard treatment options for patients who’ve had a recurrence of a resected #retroperitoneal #liposarcoma.
1
2
10
RT @DrLizConnolly: EP300::VGLL3 #rhabdomyosarcoma: a potential distinct indolent adult RMS subtype. 🚨Think of this emerging subtype if:. ✔️….
0
14
0
A/Prof @saratchanderRO paper on automated planning for Lattice Radiation Therapy has been named one of the top 10% most-viewed papers of 2023 by Medical Physics. Part-funded by ANZSA, this work paves the way for more efficient, consistent treatment of complex tumours.
2
1
2
RT @DrLizConnolly: 🧬 Genetic Predisposition in Sarcoma. Up to 20% #sarcoma may be assoc. with predisposition genes. In our 📝 we review evid….
0
41
0
We're excited to announce that we’re now on #BlueSky 🚀. Join us there as we continue to connect and share sarcoma insights. 🔹 Search for us on BlueSky using @anzsarcoma.bsky.social. 🔹Find the link to ANZSA BlueSky account here:
0
1
1
The ReLaPSe Study is now open @petermaccancercentre!.This international study being led by ANZSA aims to answer the question of which treatment option (surgery with or without preoperative radiotherapy) is best for patients diagnosed with recurrent retroperitoneal liposarcoma.
0
5
1
On #International #Women and #Girls in #Science Day, we celebrate the outstanding contributions of women in our ANZSA community, advancing sarcoma cancer research. Today, we spotlight Jacqui McGovern, winner of the Choong Dickinson Best Poster Prize from our previous ASM!
0
1
3